Subclinical Vascular Damage: Current Insights and Future Potential
- PMID: 34866906
- PMCID: PMC8633547
- DOI: 10.2147/VHRM.S242636
Subclinical Vascular Damage: Current Insights and Future Potential
Abstract
The cardiovascular risk assessment must be carried out during all the different phases of life because the cardiovascular risk and the related prevention actions are dynamic and constantly evolving. As patients age, they change their exposure to various risk factors and accumulate comorbidities by changing their subjective cardiovascular risk, so it is necessary to undertake personalized early and preventive diagnostic actions. The main approach to asymptomatic vascular disease is based on primary prevention with the adoption of a healthy lifestyle. Indeed, lifestyle influences most of the traditional risk factors. In recent years, important differences between the sexes regarding cardiovascular risk factors have emerged and in particular, risk factors specific for female sex have been identified. Women are more likely to be categorized into lower risk categories for cardiovascular disease and, as a result, receive less lifestyle counseling than men, as well as less intensive prevention. This narrative review aims to analyze CVD risk prevention in asymptomatic atherosclerosis with a look at new emerging factors. In the end, we quickly analyzed the effects of the recent pandemic on lifestyle and cardiovascular risk and the potential negative effects in the long term.
Keywords: lifestyle; microbiota; pandemic; prevention; risk factors; women.
© 2021 Mattioli et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Gender-specific, Lifestyle-related Factors and 10-year Cardiovascular Disease Risk; the ATTICA and GREECS Cohort Studies.Curr Vasc Pharmacol. 2019;17(4):401-410. doi: 10.2174/1570161116666180608121720. Curr Vasc Pharmacol. 2019. PMID: 29886832
-
Advancing early detection of organ damage and cardiovascular risk prevention: the Suzhou cardiometabolic health study protocol - exploring the role of oral microbiome and metabolic profiling in risk stratification.Front Endocrinol (Lausanne). 2025 Feb 12;16:1522756. doi: 10.3389/fendo.2025.1522756. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40013311 Free PMC article.
-
Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?BMC Public Health. 2018 Apr 2;18(1):429. doi: 10.1186/s12889-018-5263-6. BMC Public Health. 2018. PMID: 29609588 Free PMC article.
-
Sex differences in cardiovascular risk factors and disease prevention.Atherosclerosis. 2015 Jul;241(1):211-8. doi: 10.1016/j.atherosclerosis.2015.01.027. Epub 2015 Jan 28. Atherosclerosis. 2015. PMID: 25670232 Review.
-
Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy.High Blood Press Cardiovasc Prev. 2018 Sep;25(3):327-341. doi: 10.1007/s40292-018-0278-8. Epub 2018 Sep 20. High Blood Press Cardiovasc Prev. 2018. PMID: 30232768 Review.
Cited by
-
The Role of Lonp1 on Mitochondrial Functions during Cardiovascular and Muscular Diseases.Antioxidants (Basel). 2023 Feb 28;12(3):598. doi: 10.3390/antiox12030598. Antioxidants (Basel). 2023. PMID: 36978846 Free PMC article. Review.
-
Vascular Alterations Following COVID-19 Infection: A Comprehensive Literature Review.Life (Basel). 2024 Apr 24;14(5):545. doi: 10.3390/life14050545. Life (Basel). 2024. PMID: 38792566 Free PMC article. Review.
References
-
- Kotseva K, Wood D, De Bacquer D, et al. EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol. 2016;23:636–648. - PubMed
-
- Aboyans V, Ricco JB, Bartelink MEL; ESC Scientific Document Group. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018;39(9):763–816. doi:10.1093/eurheartj/ehx095 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials